AlloVir OverviewAlloVir EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ALVR.
Quarterly EBIT
-$11.83M
↓ 14.28% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$47.63M
↓ 8.99% YoY
Trailing 12 months ending Mar 31, 2026
AlloVir OverviewEBIT (Earnings Before Interest and Taxes) analysis for ALVR.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026